Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024
Viruses · 19.11.2025 · 17 (11) · 1516
DOI: 10.3390/v17111516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 19.11.2025. Verfasst von Dongqing Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing Center for Disease Control and Prevention, Shaoxing 312000, China. Hauptthemen laut MEDLINE: HIV Infections, Drug Resistance, Viral, HIV-1, Anti-HIV Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Technology Bureau of Shaoxing.
Abstract (Originalsprache)
The increasing prevalence of HIV drug resistance poses a significant challenge. This study aimed to investigate the epidemiological dynamics and molecular characteristics of pretreatment drug resistance (PDR) and acquired drug resistance in Shaoxing, Eastern China.
Methods
From 2022 to 2024, 571 newly diagnosed HIV-infected individuals and 119 individuals with antiretroviral treatment failure were enrolled. Molecular transmission networks and Bayesian analysis were employed to identify key drug-resistant clusters and trace their origins.
Results
The overall PDR prevalence was 14.4% (85/571). PDR to non-nucleoside reverse transcriptase inhibitors (NNRTIs) was 9.8% (56/571), significantly higher than to NRTIs (1.1%, 6/571) and PIs (3.7%, 21/571) (χ2 = 50.014, p < 0.001). Molecular network analysis identified large clusters harboring K103N and Q58E resistance mutations within the CRF07_BC subtype. Bayesian analysis estimated their introduction into Shaoxing from Guangdong Province around 2016 and 2017, respectively. Integrated network analysis revealed close linkages between virological failure and newly diagnosed cases, highlighting the role of treatment failure in resistance transmission.
Conclusion
Targeted interventions against specific subtypes and transmission clusters, alongside continuous resistance surveillance, are essential to curb the spread of drug-resistant HIV and optimize ART regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaoxing Center for Disease Control and Prevention, Shaoxing 312000, China.
- State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
- Department of HIV/AIDS and STDs Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.
ORCID-Profile: Jiafeng Zhang
Förderung
- Science Technology Bureau of Shaoxing
Zitieren
APA
Cao, D., Xing, H., Feng, Y., Zhang, J., Zhou, L., Jiang, Z., Chen, J., & He, T. (2025). Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024. Viruses, 17(11), 1516. https://doi.org/10.3390/v17111516
Vancouver
Cao D, Xing H, Feng Y, Zhang J, Zhou L, Jiang Z, et al. Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024. Viruses. 2025;17(11):1516. doi:10.3390/v17111516
BibTeX
@article{Cao2025,
author = {Cao, Dongqing and Xing, Hui and Feng, Yi and Zhang, Jiafeng and Zhou, Liangkang and Jiang, Zhuojing and Chen, Jinkun and He, Tingting},
title = {Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024},
journal = {Viruses},
year = {2025},
volume = {17},
number = {11},
pages = {1516},
doi = {10.3390/v17111516}
}
EUVIMED